Clinical Trials Directory

Trials / Completed

CompletedNCT00801814

Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia

Effect of Adding Escalating Doses of a Novel Highly Viscous Polysaccharide to Either a Liquid or a Solid Test Meal on Post Prandial Glycemia in Healthy Subjects: Determination of the Glycemic Reduction Index Potential (GRIP)

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Glycemic Index Laboratories, Inc · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

To determine palatability and extent to which escalating doses of a novel highly viscous polysaccharide \[NVP\] reduces postprandial glycemia when added to a liquid and a solid meal.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPolyGlycopleX (PGX)2.5 grams of PGX
DIETARY_SUPPLEMENTPolyGlycopleX (PG)5.0 grams of PGX
DIETARY_SUPPLEMENTPolyGlycopleX7.5 grams of PGX
DIETARY_SUPPLEMENTControl0g of PGX
DIETARY_SUPPLEMENTSecond Control0g of PGX

Timeline

Start date
2006-04-01
Primary completion
2006-05-01
Completion
2006-08-01
First posted
2008-12-04
Last updated
2008-12-04

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00801814. Inclusion in this directory is not an endorsement.